Compliance with the guidelines of the European Society of Cardiology and morbidity and mortality from infectious endocarditis
| Autor: | M. Rodríguez Esteban, L. Carballo Arzola, J. Ode Febles, J.A. Medina García, S. Miranda Montero, M. Farrais Villalba |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty medicine.drug_class Treatment regimen business.industry 030106 microbiology Antibiotics Retrospective cohort study General Medicine Evidence-based medicine Disease medicine.disease Treatment and control groups 03 medical and health sciences Internal medicine Propensity score matching medicine Cardiology Endocarditis business |
| Zdroj: | Revista Clínica Española (English Edition). 216:15-18 |
| ISSN: | 2254-8874 |
| DOI: | 10.1016/j.rceng.2015.09.005 |
| Popis: | Objective The antibiotic treatment recommended for infectious endocarditis (IE) has a low level of evidence. Our objective was to determine whether compliance with the recommendations of the European Society of Cardiology (ESC) was related to lower in hospital morbidity and mortality for this disease. Methods A retrospective study was conducted on 162 cases of IE diagnosed between 2005 and 2014. A propensity score-matching analysis was performed to determine the effect of treatment on hospital mortality. Results There were no differences in terms of disease complications between the treatment groups. Hospital mortality was 29.2% when the treatment was adjusted to the guidelines and 28.2% when the treatment was not adjusted (OR = 1.048; 95% CI: 0.442–2.484; p = .916). Conclusion The use of the ESC guidelines does not appear to translate into a reduction in hospital morbidity and mortality due to IE when compared with alternative antibiotic treatment regimens. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect